SlidesetHIVResistance Characteristics of different Integrase Inhibitors- Charles Boucher, MD, PhDView Slideset
SlidesetHIVAbstract-driven presentation: Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Treatment-Naïve Asian Adults: Week 144 results- Tina ZhengView Slideset
SlidesetHIVResistance Characteristics of different Integrase Inhibitors- Charles Boucher, MD, PhDView Slideset
SlidesetHIVOptimal use of integrase inhibitors in routine clinical practice- Kees Brinkman, MD, PhDView Slideset
SlidesetHIVOptimal use of integrase inhibitors in routine clinical practice- Kees Brinkman, MD, PhDView Slideset
SlidesetHIVAbstract-driven presentation: Efficacy and Safety of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide (E/C/F/TAF) in Virologically Suppressed Asian Adults with Renal Impairment: 144 Week- Ning LiView Slideset
SlidesetHIVLong-term HIV treatment: The Importance of Initial Antiretroviral Regimen Selection- Hongxin Zhao, MD, MPHView Slideset
